Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

vTv Therapeutics (VTVT) Other Accumulated Expenses (2016 - 2021)

vTv Therapeutics (VTVT) has disclosed Other Accumulated Expenses for 8 consecutive years, with $155000.0 as the latest value for Q4 2021.

  • Quarterly Other Accumulated Expenses rose 675.0% to $155000.0 in Q4 2021 from the year-ago period, while the trailing twelve-month figure was $155000.0 through Dec 2021, up 675.0% year-over-year, with the annual reading at $155000.0 for FY2021, 675.0% up from the prior year.
  • Other Accumulated Expenses hit $155000.0 in Q4 2021 for vTv Therapeutics, up from $20000.0 in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $1.1 million in Q4 2017 to a low of $20000.0 in Q4 2020.
  • Historically, Other Accumulated Expenses has averaged $300400.0 across 5 years, with a median of $142000.0 in 2018.
  • Biggest five-year swings in Other Accumulated Expenses: crashed 86.55% in 2018 and later skyrocketed 675.0% in 2021.
  • Year by year, Other Accumulated Expenses stood at $1.1 million in 2017, then plummeted by 86.55% to $142000.0 in 2018, then dropped by 9.15% to $129000.0 in 2019, then plummeted by 84.5% to $20000.0 in 2020, then surged by 675.0% to $155000.0 in 2021.
  • Business Quant data shows Other Accumulated Expenses for VTVT at $155000.0 in Q4 2021, $20000.0 in Q4 2020, and $129000.0 in Q4 2019.